Article
Healthcare & Life Sciences Private Equity Deal Tracker: Metacrine Secures $36 Million In Financing
Metacrine, based in San Diego, Calif., is a biotechnology company focused on advancing research in nuclear hormone receptors for treatment of metabolic diseases originated at the Salk Institute for Biological Studies.

McGuireWoods LLP






